Guaifenesin and Caffeine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Guaifenesin (guaifenesin) and Caffeine (caffeine). Common drug interactions include bacteraemia among females and immune system disorder among males.

The phase IV clinical study analyzes what interactions people have when they take Guaifenesin and Caffeine. It is created by eHealthMe based on reports of 43 people who take the same drugs from the FDA, and is updated regularly.

What is Guaifenesin?

Guaifenesin has active ingredients of guaifenesin. It is often used in cough. eHealthMe is studying from 12,106 Guaifenesin users. Check the latest studies of Guaifenesin.

What is Caffeine?

Caffeine has active ingredients of caffeine. It is often used in fatigue. eHealthMe is studying from 6,667 Caffeine users. Check the latest studies of Caffeine.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 31, 2026

43 people who take Guaifenesin and Caffeine together, and have interactions are studied.

Guaifenesin and Caffeine drug interactions.

What are the common drug interactions of Guaifenesin and Caffeine, by gender? *:

female:

  1. Bacteraemia (presence of bacteria in the blood)
  2. Device failure
  3. Hypoglycaemia (deficiency of glucose in the bloodstream)
  4. Hypotension (abnormally low blood pressure)
  5. Small intestinal obstruction (blockage in small intestine)
  6. Coma (state of unconsciousness lasting more than six hours)
  7. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  8. Vomiting
  9. Abdominal pain
  10. Depressed level of consciousness

male:

  1. Immune system disorder
  2. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  3. Rash
  4. Alkalosis
  5. Altered state of consciousness (altered state of mind)
  6. Blood creatine phosphokinase increased
  7. Cardiac arrest
  8. Cardiac failure
  9. Death
  10. Developmental delay

What are the common drug interactions of Guaifenesin and Caffeine, by age (0-1 to 60+)? *:

0-1:

  1. Developmental delay
  2. Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)

2-9:

n/a

10-19:

n/a

20-29:

  1. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  2. Fall
  3. Injury
  4. Alkalosis
  5. Altered state of consciousness (altered state of mind)
  6. Blood creatine phosphokinase increased
  7. Haematuria (presence of blood in urine)
  8. Ketonuria (ketones in urine)
  9. Nausea (feeling of having an urge to vomit)
  10. Overdose

30-39:

  1. Coma (state of unconsciousness lasting more than six hours)
  2. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  3. Vomiting
  4. Depressed level of consciousness
  5. Anion gap increased
  6. Blood lactic acid increased
  7. Respiratory acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease)

40-49:

  1. Immune system disorder
  2. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  3. Eye infection
  4. Migraine (headache)
  5. Chronic kidney disease
  6. Meibomian gland dysfunction (dry eyes)
  7. Abdominal pain
  8. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  9. Cardiac arrest
  10. Completed suicide (act of taking one's own life)

50-59:

  1. Dyskinesia (abnormality or impairment of voluntary movement)
  2. Loss of consciousness
  3. Migraine (headache)

60+:

  1. Bacteraemia (presence of bacteria in the blood)
  2. Device failure
  3. Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection)
  4. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  5. Drug abuse
  6. Drug ineffective
  7. Overdose
  8. Psoriasis (immune-mediated disease that affects the skin)
  9. Pulmonary mass
  10. Rash

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 9 people, 20.93%
  2. Insomnia (sleeplessness): 8 people, 18.60%
  3. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 8 people, 18.60%
  4. Rashes (redness): 7 people, 16.28%
  5. Constipation: 7 people, 16.28%
  6. Itching: 7 people, 16.28%
  7. Pain: 6 people, 13.95%
  8. Asthma: 6 people, 13.95%
  9. Headache (pain in head): 6 people, 13.95%
  10. Diarrhea: 5 people, 11.63%

* Approximation only. Some reports may have incomplete information.

Do you take Guaifenesin and Caffeine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Guaifenesin and Caffeine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Guaifenesin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Caffeine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Guaifenesin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Caffeine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on guaifenesin and caffeine (the active ingredients of Guaifenesin and Caffeine, respectively), and Guaifenesin and Caffeine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: